NANOMEDICINE RESEARCH AREAS AND GROUPS

Our research focus into three interconected experimental areas and two technological platforms covering different aspects of nanomedicine research and biomedical applications.

AREA 1: BIOMARKERS AND THERAPEUTIC TARGETS

DRUG DELIVERY AND TARGETING. Principal investigator: Dr Simó Schwartz Jr

MOLECULAR ONCOLOGY. Principal investigator: Dr Diego Arango

IMMUNOBIOLOGY. Principal investigator: Dr Joan Sayós

GENETICS AND FUNCTIONAL GENOMICS. Principal investigator: Dr Julián Cerón

CELLULAR PHYSIOPHATOLOGY (RARE DISEASES). Principal investigator: Dr Carmen Domínguez

RENAL PHYSIOPATHOLOGY. Principal investigator: Anna Meseguer

NEUROMUSCULAR AND MITOCHONDRIAL DISEASES . Principal investigator: Dr Toni Andreu

AGING BASIC RESEARCH. Principal investigator: Dr. Jaume Alijotas

AREA 2: EXPERIMENTAL CHEMISTRY AND APPLIED NANOTECHNOLOGY

EXPERIMENTAL MEDICAL CHEMISTRY. Principal Investigator: Under Recruitment

GENOMIC THERAPIES. Principal Investigator: Under Recruitment

APPLIED BIOMATERIALS AND NANOTECNOLOGY. Principal investigators: Dr. Francesc Miró

AREA 3: FUNCTIONAL STUDIES AND TARGET VALIDATION

FUNCTIONAL VALIDATION AND PRECLINICAL RESEARCH. Principal Investigator: Dr. Ibane Abasolo

CLINICAL STUDIES. Principal Investigator: Dr. Eloi Espín

TECHNOLOGICAL PLATFORMS FOR NANOMEDICINE

In vitro PLATFORM

In vivo PLATFORM